Back to Search
Start Over
Correction: A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren’s syndrome patients
- Source :
- Trials, Vol 24, Iss 1, Pp 1-1 (2023)
- Publication Year :
- 2023
- Publisher :
- BMC, 2023.
- Subjects :
- Medicine (General)
R5-920
Subjects
Details
- Language :
- English
- ISSN :
- 17456215
- Volume :
- 24
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Trials
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.145a0614a8949e29392e5431728f81e
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s13063-023-07546-z